{"id":666563,"date":"2023-09-06T20:00:02","date_gmt":"2023-09-06T20:00:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=666563"},"modified":"2023-09-06T20:00:02","modified_gmt":"2023-09-06T20:00:02","slug":"gonorrhea-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market-companies-evofem-biosciences-glaxosmithkline-entasis-therapeutics","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/gonorrhea-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market-companies-evofem-biosciences-glaxosmithkline-entasis-therapeutics_666563.html","title":{"rendered":"Gonorrhea Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies &#8211; Evofem Biosciences, GlaxoSmithKline, Entasis Therapeutics"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1693917362.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Gonorrhea Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies - Evofem Biosciences, GlaxoSmithKline, Entasis Therapeutics\" src=\"https:\/\/www.abnewswire.com\/uploads\/1693917362.jpeg\" alt=\"Gonorrhea Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Market | Companies - Evofem Biosciences, GlaxoSmithKline, Entasis Therapeutics\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Gonorrhea Market Trends<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight&#8217;s &#8220;Gonorrhea Market Insights, Epidemiology, and Market Forecast-2032&#8221; report delivers an in-depth understanding of the Gonorrhea, historical and forecasted epidemiology as well as the Gonorrhea market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n<p style=\"text-align: justify;\">DelveInsight has launched a new report on &#8220;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/gonorrhea-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\"><strong>Gonorrhea &#8211; Market Insights, Epidemiology, and Market Forecast-2032<\/strong><\/a>&rdquo;.<\/p>\n<p style=\"text-align: justify;\"><strong>Some of the key facts of the&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/gonorrhea-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\">Gonorrhea Market Report<\/a>:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>As per CDC, the gonorrhea rate among males increased 6.0% (200.8 to 212.8 cases per 100,000 males) and the rate among females increased 3.6% (140.7 to 145.8 cases per 100,000 females). During 2014&ndash;2018, the rate among males increased 78.7% (119.1 to 212.8 cases per 100,000 males) and the rate among females increased 45.2% (100.4 to 145.8 cases per 100,000 females) in the US.&nbsp;<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Key benefits of the report:<\/strong><\/p>\n<ol style=\"text-align: justify;\" start=\"1\">\n<li>Gonorrhea market report covers a descriptive overview and comprehensive insight of the Gonorrhea Epidemiology and Gonorrhea&nbsp; market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) &amp; Japan.)<\/li>\n<li>The Gonorrhea market report provides insights on the current and emerging therapies.<\/li>\n<li>Gonorrhea market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/li>\n<li>The Gonorrhea market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Gonorrhea market.<\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><strong>Got queries? Click here to know more about the&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/gonorrhea-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\">Gonorrhea Market Landscape<\/a>.<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Gonorrhea Market&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">The dynamics of the&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/gonorrhea-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\"><strong>Gonorrhea market<\/strong><\/a>&nbsp;are anticipated to change in the coming years owing to the expected launch of emerging therapies by key companies such as <strong>Evofem Biosciences, GlaxoSmithKline, Entasis Therapeutics<\/strong>, and others during the forecasted period 2019-2032.<\/p>\n<p style=\"text-align: justify;\"><strong>Gonorrhea Pipeline Therapies and Key Companies&nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>EVO100: Evofem Biosciences<\/li>\n<li>Gepotidacin (GSK2140944): GlaxoSmithKline<\/li>\n<li>Zoliflodacin (ETX0914): Entasis\/GARDP<\/li>\n<li>And others.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Gonorrhea Market Drivers&nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Increasing prevalence of Gonorrhea<\/li>\n<li>Improved awareness on Gonorrhea<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Table of Contents<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Report Introduction<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary<\/p>\n<p style=\"text-align: justify;\">3. SWOT analysis<\/p>\n<p style=\"text-align: justify;\">4. Gonorrhea Patient Share (%) Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Gonorrhea Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">6. Gonorrhea Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">7. Gonorrhea Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Country-Specific Patient Population of Gonorrhea&nbsp;<\/p>\n<p style=\"text-align: justify;\">9. Gonorrhea Current Treatment and Medical Practices<\/p>\n<p style=\"text-align: justify;\">10. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">11. Gonorrhea Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">12. Gonorrhea Market Outlook<\/p>\n<p style=\"text-align: justify;\">13. Country-Wise Gonorrhea Market Analysis (2019&ndash;2032)<\/p>\n<p style=\"text-align: justify;\">14. Market Access and Reimbursement of Therapies<\/p>\n<p style=\"text-align: justify;\">15. Market drivers<\/p>\n<p style=\"text-align: justify;\">16. Market barriers<\/p>\n<p style=\"text-align: justify;\">17. Appendix<\/p>\n<p style=\"text-align: justify;\">18. Gonorrhea Report Methodology<\/p>\n<p style=\"text-align: justify;\">19. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">20. Disclaimer<\/p>\n<p style=\"text-align: justify;\">21. About DelveInsight<\/p>\n<p style=\"text-align: justify;\"><strong>Click here to read more about&nbsp;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/gonorrhea-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\">Gonorrhea Market Outlook 2032<\/a>.<\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Kritika Rehani<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=gonorrhea-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market-companies-evofem-biosciences-glaxosmithkline-entasis-therapeutics\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +91-9650213330<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=gonorrhea-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market-companies-evofem-biosciences-glaxosmithkline-entasis-therapeutics\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gonorrhea Market Trends DelveInsight&#8217;s &#8220;Gonorrhea Market Insights, Epidemiology, and Market Forecast-2032&#8221; report delivers an in-depth understanding of the Gonorrhea, historical and forecasted epidemiology as well as the Gonorrhea market trends in the United States, EU5 (Germany, Spain, Italy, France, and &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/gonorrhea-market-analysis-of-epidemiology-pipeline-products-and-key-companies-working-in-the-market-companies-evofem-biosciences-glaxosmithkline-entasis-therapeutics_666563.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-666563","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/666563","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=666563"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/666563\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=666563"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=666563"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=666563"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}